Drug-Target Interaction — Revision Notes

⚡ 30-Second Revision

Drug Target: — Macromolecule (protein, nucleic acid) drug binds to.
Agonist: — Binds, activates receptor, mimics natural ligand (e.g., Morphine).
Antagonist: — Binds, blocks receptor, prevents activation (e.g., Antihistamines).
Enzyme Inhibitor: — Blocks enzyme activity (e.g., Aspirin inhibits COX).
Competitive Inhibitor: — Binds to active site, competes with substrate.
Non-competitive Inhibitor: — Binds to allosteric site, changes enzyme shape.
Binding Forces: — Primarily non-covalent (H-bonds, ionic, van der Waals, hydrophobic).
Specificity: — Crucial for minimizing side effects.
Induced Fit Model: — Drug and target undergo conformational changes upon binding.

2-Minute Revision

Drug-target interaction is the specific binding of a drug molecule to a biological macromolecule (target) to produce a therapeutic effect. Key targets include receptors, enzymes, ion channels, and nucleic acids.

Drugs can act as agonists, activating receptors like natural ligands (e.g., morphine on opioid receptors), or as antagonists, blocking receptors to prevent activation (e.g., antihistamines on histamine receptors).

Many drugs are enzyme inhibitors, reducing enzyme activity (e.g., aspirin inhibiting COX enzymes). Inhibition can be competitive (drug competes with substrate for the active site) or non-competitive (drug binds to an allosteric site, altering enzyme shape).

The binding is primarily mediated by weak, non-covalent forces (hydrogen bonds, ionic, van der Waals, hydrophobic interactions), which ensure high specificity and reversible action. The 'induced fit' model describes the dynamic conformational changes in both drug and target upon binding, optimizing the interaction.

Understanding these interactions is fundamental to pharmacology and drug design.

5-Minute Revision

Drug-target interaction forms the bedrock of drug action, explaining how medicines exert their effects at a molecular level. A drug target is typically a large biological molecule, most commonly a protein such as a receptor, enzyme, ion channel, or transporter, though nucleic acids can also serve as targets.

The interaction is highly specific, akin to a 'lock and key' mechanism, though the more dynamic 'induced fit' model better describes how both the drug and target can undergo conformational changes to achieve optimal binding.

The forces driving these interactions are predominantly non-covalent:

1
Hydrogen bonds: — Crucial for directional specificity.
2
Ionic interactions: — Strong electrostatic attractions between charged groups.
3
Van der Waals forces: — Weak, short-range attractions important for overall fit.
4
Hydrophobic interactions: — Driving non-polar regions together in an aqueous environment.

Based on their interaction, drugs can be classified:

Agonists: — Bind to receptors and activate them, mimicking natural ligands to elicit a response. *Example: Morphine acts as an agonist on opioid receptors to relieve pain.*
Antagonists: — Bind to receptors but do not activate them; instead, they block the binding of natural ligands or agonists, preventing a response. *Example: Antihistamines block histamine receptors to prevent allergic reactions.*
Enzyme Inhibitors: — Reduce or block the activity of enzymes. These can be:

* Competitive: The inhibitor structurally resembles the natural substrate and competes for the active site. *Example: Aspirin inhibits cyclooxygenase (COX) enzymes.* * Non-competitive (Allosteric): The inhibitor binds to a site other than the active site (allosteric site), causing a conformational change that reduces enzyme efficiency. *Example: Heavy metal ions often act as non-competitive inhibitors.*

Other examples include tranquilizers (like benzodiazepines) which enhance the effect of the inhibitory neurotransmitter GABA, and antimicrobials which target bacterial-specific processes. Antacids are an exception, acting by chemical neutralization rather than specific drug-target binding. High specificity is vital for minimizing undesirable side effects by ensuring the drug acts predominantly on its intended target.

Prelims Revision Notes

Drug-Target Interaction: NEET Essential Facts

1. What are Drug Targets?

Biological macromolecules that drugs bind to.
Primarily proteins: Receptors, Enzymes, Ion Channels, Transporters.
Also nucleic acids (DNA/RNA).

2. Types of Drug Action based on Target Interaction:

Agonist:

* Binds to receptor, activates it. * Mimics natural ligand (e.g., hormone, neurotransmitter). * Produces biological response. * *Example: Morphine (opioid receptor agonist).*

Antagonist:

* Binds to receptor, but *does not activate* it. * Blocks natural ligand/agonist binding. * Prevents/reduces biological response. * *Example: Antihistamines (histamine receptor antagonists).*

Enzyme Inhibitor:

* Reduces or blocks enzyme activity. * Competitive Inhibitor: * Resembles natural substrate. * Binds to enzyme's active site, competing with substrate. * Effect can be overcome by increasing substrate concentration.

* *Example: Aspirin (inhibits COX enzymes).* * Non-competitive (Allosteric) Inhibitor: * Binds to a site other than the active site (allosteric site). * Causes conformational change, reducing enzyme efficiency.

* Effect *cannot* be overcome by increasing substrate concentration.

3. Forces in Drug-Target Binding:

Mainly non-covalent interactions (weak, reversible):

* Hydrogen bonds: Crucial for directionality and specificity. * Ionic interactions: Between charged groups. * Van der Waals forces: Weak, short-range, cumulative. * Hydrophobic interactions: Clustering of non-polar regions.

Covalent bonds: — Less common, often lead to irreversible effects (e.g., 'suicide inhibitors').

4. Key Concepts:

Specificity/Selectivity: — Drug's ability to bind preferentially to one target; minimizes side effects.
Induced Fit Model: — Both drug and target undergo conformational changes upon binding for optimal fit.

5. Important Drug Examples & Their Targets/Mechanisms (NCERT Focus):

Antacids: — Neutralize excess stomach acid (e.g., $ext{Mg(OH)}_2$, $ext{Al(OH)}_3$). *Not a classical receptor interaction.*
Antihistamines: — Block histamine receptors (e.g., Cimetidine, Ranitidine, Brompheniramine, Terfenadine).
Tranquilizers: — Enhance GABA action in CNS (e.g., Benzodiazepines like Diazepam, Chlordiazepoxide; Barbiturates).
Analgesics:

* Non-narcotic: Inhibit COX enzymes, reduce prostaglandin synthesis (e.g., Aspirin, Ibuprofen). * Narcotic: Agonists at opioid receptors (e.g., Morphine).

Antimicrobials: — Target bacterial processes (e.g., Penicillin inhibits cell wall synthesis).
Antiseptics/Disinfectants: — Generally non-specific, denature proteins/disrupt membranes of microbes.

Vyyuha Quick Recall

Target Always Expects Interactions: Agonists Activate, Antagonists Arrest, Enzyme Inhibitors Interfere."

Target: What the drug binds to.
Always Expects Interactions: Reminds of the binding process.
Agonists Activate: Agonists turn on the target.
Antagonists Arrest: Antagonists block or stop the target's action.
Enzyme Inhibitors Interfere: Enzyme inhibitors block enzyme activity.